1. P648 Clinical feasibility of dried blood sampling for infliximab in IBD patients. (16th January 2018) Authors: Berends, S; D'Haens, G; Bloem, K; Schaap, J; De Vries, A; Rispens, T; Mathôt, R Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P724 Unchanged infliximab serum concentrations after switching from the originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease: Results from a prospective study (SECURE). (16th January 2018) Authors: Strik, A; van de Vrie, W; Bloemsaat-Minekus, J; Nurmohamed, M; Bossuyt, P; Bodelier, A; Rispens, T; van Megen, Y; D'Haens, G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0025 Antidrug antibodies detection is strongly influenced by the type of assay used. (15th June 2017) Authors: Ruwaard, J; Marsman, AF; Nurmohamed, MT; Velthuis, H te; Bloem, K; Rispens, T; Wolbink, GJ Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0349 Methotrexate reduces adalimumab immunogenicity in patients with spondyloarthritis: a randomized clinical trial. (15th June 2017) Authors: Ducourau, E; Rispens, T; Dernis, E; Guilchard, F Le; Andras, L; Perdriger, A; Lespessailles, E; Martin, A; Cormier, G; Armingeat, T; Devauchelle-Pensec, V; Solau-Gervais, E; Goff, B Le; Vries, A de; Piver, E; Ternant, D; Goupille, P; Mulleman, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up. Issue 10 (7th May 2014) Authors: Kneepkens, E L; Krieckaert, C L M; van der Kleij, D; Nurmohamed, M T; van der Horst-Bruinsma, I E; Rispens, T; Wolbink, G J Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 10(2015) Page Start: 1825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies. Issue 10 (12th May 2014) Authors: Suurmond, J; Rivellese, F; Dorjée, A L; Bakker, A M; Rombouts, Y J P C; Rispens, T; Wolbink, G; Zaldumbide, A; Hoeben, R C; Huizinga, T W J; Toes, R E M Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 10(2015) Page Start: 1915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP27 Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study. (21st January 2022) Authors: Volkers, A; Wieske, L; van Dam, K; Steenhuis, M; Stalman, E; Kummer, L; van Kempen, Z; Killestein, J; Tas, S; Boekel, L; Wolbink, G; Takkenberg, B; Spuls, P; Bosma, A; Rutgers, B; Verschuuren, J; van Ouwerkerk, L; van der Woude, D; van Paassen, P; Busch, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis. (27th April 2015) Authors: Harrer, A; Pilz, G; Wipfler, P; Oppermann, K; Sellner, J; Hitzl, W; Haschke-Becher, E; Afazel, S; Rispens, T; van der Kleij, D; Trinka, E; Kraus, J Journal: Clinical and experimental immunology Issue: Volume 180:Number 3(2015:Jun.) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Elevated Fab glycosylation of anti-hinge antibodies. (2nd January 2023) Authors: Koers, J; Derksen, NIL; Falkenburg, WJJ; Ooijevaar-de Heer, P; Nurmohamed, MT; Wolbink, GJ; Rispens, T Journal: Scandinavian journal of rheumatology Issue: Volume 52:Number 1(2023) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0177 N-glycosylation sites in the variable domain of b cell receptors specific for citrullinated antigens. (15th June 2017) Authors: Slot, LM; Vergroesen, RD; Hafkenscheid, L; Koning, MT; Rispens, T; Veelken, H; Toes, RE; Scherer, HU Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗